Sean Wieland
Stock Analyst at Piper Sandler
(1.93)
# 3,197
Out of 5,042 analysts
31
Total ratings
50%
Success rate
1.69%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $31.08 | +76.96% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $25.99 | +38.51% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $5.57 | +2,054.40% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $48.78 | -87.70% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $66.84 | -34.17% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $220.52 | +4.75% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $9.46 | +2,976.11% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $31.08
Upside: +76.96%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $25.99
Upside: +38.51%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $5.57
Upside: +2,054.40%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $48.78
Upside: -87.70%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $66.84
Upside: -34.17%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $220.52
Upside: +4.75%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $9.46
Upside: +2,976.11%